
|Videos|September 7, 2021
Transperineal biopsy device PrecisionPoint shows promise
Author(s)Urology Times staff
“Through these 2 small punctures, we can manipulate the device with the methodology to sample the entire prostate, both anterior apical and the posterior regions, where we find the vast majority of our cancers,” says Matthew A. Allaway, MD.
Advertisement
In this video, Matthew J. Allaway, MD, discusses the The PrecisionPoint Transperineal Access System, a new and efficient methodology for detecting prostate cancers in patients. Allaway is the founder and president of Perinealogic, urologist and managing partner at Urology Associates, Cumberland, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










